The effects of pomegranate seed (PSO) with resistance exercise on insulin resistance and cardiovascular risk factors in non-athletic me
Not Applicable
Completed
- Conditions
- Obesity.Obesity
- Registration Number
- IRCT2016092730023N1
- Lead Sponsor
- Rajai Teacher Training University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Inclusion Criteria: Healthy young men with no previous record of any specific drug use? without experience of regular physical activity in two year before beginning of the study.
Exclusion Criteria
Unhealthy? Doing regular exercise during the last two years.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting insulin. Timepoint: Before and after 4 weeks. Method of measurement: Elisa.
- Secondary Outcome Measures
Name Time Method ipid profiles (total cholesterol, triglycerides, and low high-density cholesterol). Timepoint: Before and after 4 weeks. Method of measurement: Enzymatic.;Insulin resistance index. Timepoint: Before and after 4 weeks. Method of measurement: Elisa.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pomegranate seed oil's impact on insulin resistance in obese men?
How does resistance exercise combined with pomegranate seed oil compare to standard obesity treatments in improving cardiovascular risk factors?
Are there specific biomarkers that predict response to pomegranate seed oil and resistance exercise in non-athletic men with obesity?
What are the potential adverse events associated with pomegranate seed oil supplementation during resistance training in obese individuals?
What other natural compounds or combination therapies show promise in targeting metabolic syndrome and cardiovascular risk factors in obesity?